Oculeve Marks Big Win For Medtech

Medtech Talk
15/07/2015 14 min
Oculeve Marks Big Win For Medtech

Listen "Oculeve Marks Big Win For Medtech"

Descargar episodio

Episode Synopsis

Oculeve, a stealthy start-up with backing from Kleiner, NEA and Versant, opted to sell its neurostim treatment for Dry Eye to Ophthalmology Leader Allergan.

More episodes of the podcast Medtech Talk

Episode: 201 - Stacy Enxing Seng on Why People and Culture Determine Medtech 18/11/2025
Episode: 200 - Ridhi Tariyal on Bridging the Data Gap in Women’s Health 21/10/2025
From Boston Scientific to Entrepreneur: Chas McKhann’s Medtech Journey 26/08/2025
Innovating for Niche Populations with Eric Chehab and James Wall 29/07/2025
Episode: 197 - Fireside Chat: How Michael Mahoney Built a Culture of Disciplined Innovation at Boston Scientific 15/07/2025
Episode: 196 - Eric Wichems on Building a Company You Want to Work For 21/05/2025
Episode: 195 - John Woock on Crossing the Chasm from Clinical to Commercial 29/04/2025
Episode: 194 - Douglas Kelly on the Value of Innovation and Breakthrough Designation 27/03/2025
Episode:193 - Dr. Billy Cohn on Limitless Innovation and Finding Resources Everywhere 18/02/2025
Episode: 192 - Michael Jaff's Multi-Perspective Insights Into Healthcare 02/12/2024
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA